Home
English (UK)
中文版
Webinars
1:1 Scheduling
Virtual Booth
Video Pitch
FAQs
Contact
How to use 1:1 video conference
Forgot your
password?
Login
Close
Search
Organisations
Attendees
Print
Groups
All
Biotechnology - Research Tool and Service
Biotechnology - Therapeutics
Digital Health
Investor
Medical Technology
Non-Profit Organization/Government Entity
Other
Pharma
Professional Services and Consulting
Company Size (Fulltime employees)
1-10
11-50
51-200
201-500
501-1000
1001-5000
5000+
Partnering Objectives
Fundraising
Licensing-in
Licensing-out
Looking for clients and partners
Looking for companies to invest
Looking for services
Other
Recruiting new team member
Functionality
Management
Business Development
Human Resources
Sales and Marketing
Investment
Other
Research and Clinical
Research and Development
Preclinical External Innovation
Scientist
Customer Planner
Corporate Development
Headquartner in China
Yes
No
Biotech/Pharma Category
505b2
Antibodies
Artificial Intelligence (AI)
Autoimmune
Bioinformatics
Biosimilar
Cardiovascular
CMO
CNS
CRO
Dermatology
Diagnostics
Digital Health
Drug Delivery
Drug Discovery
Endocrine-Metabolic
Gastrointestinal
Gene-Cell therapy
Generics
Genomics
Hematology
Hepatic
Immunotherapy
infectious Disease
inflammation
Microbiome
Natural Compounds
Neurology
Nucleic acid drugs
Oncology
Orphan-Rare Disease
Other
Peptides
Personalized Medicine
Platform Technology
Proteins
pulmonary
Regenerative Medicine
Research Tools
Small molecules
Solid tumor
Stem cells
Vaccines
Biotech/Pharma Asset Stage
Discovery and development
FDA review
On the market
Phase I
Phase II
Phase III
Preclinical
Medtech Category
Aesthetic Medicine
Delivery devices
Dental devices
Electro mechanical devices
Electromechanical devices
Imaging devices
Implantable devices
In vitro diagnostic devices
Ophthalmic and optical devices
Orthopedic Devices
Other
Regenerative medicine
Rehabilitation Devices
Respiratory devices
Reusable instruments
Single use devices
Surgical Devices
Wearable Devices
Medtech Development Stage
Clinical study
Conceptualizing
Discovery and development
FDA review
On the market
Preclinical research
Prototyping
Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
Countries
All
Bahrain
Bulgaria
Canada
China
Ethiopia
Finland
France
Germany
India
Israel
Italy
Japan
Lebanon
Monaco
Netherlands
Singapore
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
United States
Reset
Order alphabetically
Order by date approved
1
2
3
4
31 results found
Zhaoyou Investment
2nd market PE,
about 300M RMB total value,
mainly focus on A-share market and startup on H-share market,
concentrating on high-speed developing industrials especially in Healthcare, including Big Biopharma/Superior Biotech companies.
Website:
Newly set-up, currently no official website
Company Size (Fulltime employees)
Nov-50
Year of foundation
2016
Partnering Objectives
Looking for companies to invest
Please specify your partnering goal
Currently UNABLE to invest in startups' early stages, focusing on digging out 2nd market valued stocks
Headquartner in China
Yes
Biotech/Pharma Category
505b2
Antibodies
Autoimmune
Biosimilar
CMO
CRO
Cardiovascular
Diagnostics
Digital Health
Drug Delivery
Gene-Cell therapy
Hepatic
Immunotherapy
Microbiome
Neurology
Nucleic acid drugs
Oncology
Orphan-Rare Disease
Peptides
Platform Technology
Proteins
Solid tumor
Stem cells
Vaccines
infectious Disease
inflammation
Mr. Jasper Wu
Head of Research
Functionality
Research and Development
1
2
3
4
31 results found